CryJ2-LAMP-vax

N/A

Report date: 2023/11/01 20:08:59

Base Information

Drug NameCryJ2-LAMP-vax
Drug Alias NameCryJ2-DNA-lysosomal associated membrane protein plasmidJapanese red cedar pollen allergy immunotherapy - ImmunomicJapanese red cedar LAMP vaccineCryJ2 DNA LAMP plasmid vaccineSugi allergy vaccine +[12] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionTh1 cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncImmunomic Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsConjunctivitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A